SCHEMBL3136072

SCHEMBL3136072

CCCCNc1nc(N(CCCC)C2CC(C)(C)NC(C)(C)C2)nc(N(CCCC)C2CC(C)(C)NC(C)(C)C2)n1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 2/20 0.33
DNM2 P50570 7/20 0.30
MERTK Q12866 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367814 0.96 DNM2 (0.34) DNM2
SCHEMBL13415271 0.95 DNM2 (0.36) SLC29A1DNM2
SCHEMBL13415272 0.95 DNM2 (0.36) SLC29A1DNM2
SCHEMBL3133092 0.95 DNM2 (0.36) SLC29A1DNM2
SCHEMBL13290125 0.95 DNM2 (0.34) SLC29A1DNM2MERTK
SCHEMBL3131814 0.95 DNM2 (0.34) SLC29A1DNM2MERTK
SCHEMBL15961463 0.95 ESR1 (0.32)
SCHEMBL10167577 0.94 NPY1R (0.33) SLC29A1
SCHEMBL11338890 0.94 SLC29A1 (0.33) SLC29A1DNM2
SCHEMBL10135470 0.93 NPY1R (0.33) SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2010-03-25 US disclosed
US-5250292-A Use of cyclic organic amines in dermatological compositions SIGMA PRODOTTI CHIMICI S.P.A. (IT) 1993-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074083-A1 RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION SEM1, WDR5, WDR1 SLC29A1 3656/4885DNM2 2467/4885MERTK 2018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.